Probiotic drink may ease PCOS-Related fertility issues
NCT ID NCT07711782
First seen Jul 17, 2026 · Last updated Jul 17, 2026
Summary
This study explores whether drinking water kefir daily for two months can improve reproductive health and cholesterol levels in women aged 18–25 with polycystic ovary syndrome (PCOS). Participants follow a calorie-controlled diet, with one group also consuming kefir. Researchers measure changes in lipid profiles and key reproductive hormones like FSH and LH.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- water kefir (a probiotic drink)
- What this could lead to
- If effective, daily kefir could offer a simple, natural way to improve hormone balance and cholesterol levels in young women with PCOS.
- What could go wrong
- This is a small, early-stage study with only 50 participants, so results may not apply broadly. Kefir's effects on reproductive health are not yet proven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
50 people
The number who actually took part.
- Started
-
Jan 2026
- Finished
-
Apr 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 25 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Females of age 18-25 will be selected. * Females suffering from amenorrhea or cycle longer then 35days were selected. * Females with PCOS were selected. * Females with BMI 18.5-29.9 were selected in this research. * Females with thyroid issues were selected. Exclusion Criteria: * Pregnant and breast-feeding females were not included. * Those who smoke were not included. * Those who consume alcohol were not included. * Those suffering from endocrine diseases were not be included. * Those taking lipid- lowering drugs or blood pressure regulating medications were not be included. * Those taking antibiotics or medications related to PCOS treatment or vitamin-mineral or probiotics within 1 month prior to study inclusion.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Polycystic ovarian syndrome (PCOS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The University of Lahore
Lahore, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a common ED drug boost fertility in PCOS?
- Could a daily powder ease PCOS symptoms? a trial puts it to the test.
- Ancient herb meets modern science: could ashwagandha ease PCOS symptoms?
- Can an AI chatbot ease fertility worries for young cancer survivors?
- Can a daily supplement boost fertility? a new trial investigates
- Music as medicine: could a playlist reduce IUD pain?